STAA

STAAR Surgical Company

Price

$24.66

return (12m)

-11.80%

p/e

341.67

p/bv

3.59

DIVIDEND YIELD

0.00%

STAA price

STAAR Surgical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment STAA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.25%

3 months

-24.79%

1 year

-11.80%

2 years

-35.60%

5 years

-81.51%

10 years

168.04%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals STAA

Valuation

P/E

341.67

Sector -2.19

Industry 1.21

P/BV

3.59

Sector 2.22

Industry 2.11

P/Revenue (PSR)

3.86

Sector 2.01

Industry 0.78

EV/EBITDA

84.12

Sector -17.81

Industry -25.30

EV/EBIT

111.93

Sector -26.72

Industry -18.04

P/EBITDA

25.84

Sector 0.36

Industry 0.18

P/EBIT

32.00

Sector -3.34

Industry 1.26

P/Total Assets

2.76

Sector 1.23

Industry 0.86

P/Net Current Assets

5.64

Sector -27.35

Industry -12.37

P/Working Capital

4.88

Sector -4.54

Industry -49.48

EPS

0.08

Sector -0.87

Industry -0.55

BVPS

7.31

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

76.63%

Sector 43.36%

Industry 31.53%

EBITDA Margin

14.37%

Sector -323.65%

Industry -73.39%

EBIT Margin

10.80%

Sector -194.57%

Industry -11.94%

Operating Margin

12.07%

Sector -24.37%

Industry -9.87%

Net Profit Margins

1.13%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.20

Sector 0.12

Industry 0.22

Profitability

ROE

1.05%

Sector -33.82%

Industry -37.56%

ROA

0.81%

Sector -29.63%

Industry -17.56%

ROIC

11.20%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

4.66

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-13.50

Sector -1.47

Industry -31.86

Net Debt / EBIT

-17.97

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.50

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.77

Sector 0.42

Industry 0.25

Liabilities/Assets

0.23

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

8.06%

Sector -

Industry -

5Y Earnings CAGR

-32.55%

Sector -

Industry -

FAIR VALUE OF STAAR Surgical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$24.66

Fair Value

$3.63

Upside Return potential.

-85.29%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals STAA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
STAA STAAR Surgical Company	$24.66	-11.90%	0.00%	341.67	3.59	1.05%	1.13%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

STAA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT STAAR Surgical

STAAR Surgical Company

Average Investor10 user rating

4.0 (0 people)

United States

40 years

Founded: 1986

1983

Time since IPO - 43 years

550

Employees

STAAR Surgical Company (United States) is listed on the Nasdaq and has a market capitalization of $1.31 billion, with shareholders equity totaling $365.40 million.

The company employs approximately 550 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, STAAR Surgical Company reported $339.58 million in revenue, generating net income of $3.84 million.

Key financial metrics include a P/E ratio of 341.67, a price-to-book (P/B) ratio of 3.59, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker STAA.

Market cap

$1.31 billion

Net worth

$365.40 million

$365,400,000.00

Assets

$475.20 million

$475,200,000.00

Total Shares Outstanding

50.00 million

50,000,000

Average Daily Trading Volume

$861.61 Thousand

$861,614.92

Sector

Health

Industry

Medical Supplies and Equipment

STAA

STAA revenue and profits

Financial Results STAA

DRAG THE FRAME TO SEE MORE DATA

STAA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87